Introduction
Classical swine fever virus (CSFV) or hog cholera virus, bovine viral diarrhoea virus (BVDV) and border disease virus (BDV) belong to the genus Pestivirus of the family Flaviviridae (Francki et al., I991) . CSFV causes a highly contagious and often fatal disease in pigs, characterized by fever and haemorrhages, and can run an acute or chronic course. Outbreaks of classical swine fever occur in several European countries and cause large economic losses. Vaccination with the live-attenuated CSFV vaccine strain C protects pigs from classical swine fever (Terpstra & Wensvoort, 1988) . However, these vaccinated animals cannot be serologicatly distinguished from animals infected with field strains of CSFV, which hampers controlled eradication of CSFV.
The genome of pestiviruses, a positive-stranded RNA molecule of about 12"5 kb, encodes one hypothetical polyprotein (Co]lett et al., 1988; Meyers et al., 1989; Moormann et al., 1990a) . The genes encoding the structural proteins of CSFV, capsid C and envelope glycoproteins E rns, E1 and E2 have been mapped on the 5' part of the genome (Moormann e~ al., 1990b; Stark et al., 1990; Thiel et aI., 199I; Rfimenapf et al., 1993) . The nomenclature of the pestivirus proteins used in Author for correspondence: P, A. van Rijn.
Fax +31 320 238050. e-mail P.A.VANRUN@ID.DLO.NL this paper will be proposed to the ICTV by the Flaviviridae Study Group. In our previous papers glycoprotein E rns was called E2 (gp44-48), glycoprotein E1 was called E3 (gp31) and glycoprotein E2 was called EI (for references see Moormann et aI., 1996) . Pestiviruses are structurally and antigenically closely related; infection with one virus induces, to a varying extent, antibodies (Abs) which cross-react with other members of the Pestivirus genus (Moennig & Plagemann, I992) . Nevertheless, most monoclona[ antibodies (MAbs) directed against structural proteins discriminate between CSFV and BVDV strains (Wensvoort et al., 1989; Weiland et al., 1990 Weiland et al., , 1992 Edwards et at., 199I; Paton et aL, 1992) .
MAbs directed against the most antigenic envelope glycoprotein E2 (gp51-54) of CSFV have been isolated (Wensvoort et al., I986, 1989b; Weiland et al., 1990 Weiland et al., , 1992 . With a panel of 13 MAbs, four antigenic domains, A, B, C and D, have been identified on E2 of CSFV strain Brescia. Domains A, B and C contain epitopes for neutralizing MAbs (Wensvoort, 1989a) . These antigenic domains have been mapped to the N-terminal half of E2 and are located on two independent structural units in a proposed model of the antigenic structure of E2 (Fig. 1; van Rijn et al., 1994) . One structural antigenic unit consists of domains B and C (unit B/C), and the other contains a highly conserved domain A (unit A). The latter unit also contains a hydrophobic region, which is highly conserved among all pestiviruses. Although MAbs directed against envelope glycoprotein E rns can also neutralize the virus (Wensvoort, 1989b; Weiland et aL, I992) , the contribution to protection of the humoral immune response against E rns in the natural host is not clear. Except for E2, none of the structural proteins of CSFV, expressed by use of a vaccinia virus vector, induced detectable neutralizing Abs (R6menapf et al., 1991; K6nig et aI., 1995) . The immune response induced by E2 is sufficient for protection. Vaccination of pigs with a recombinant pseudorabies virus which expresses CSFV E2 protects swine from classical swine fever (van Zijl et aI., 1991) . More recently, it has been shown that vaccination with E2 protein expressed in insect cells protects swine against a lethal challenge with CSFV strain Brescia (HuM eta]., 1993).
Here we describe the production of several mutant E2 proteins in insect cells, which were used in order to study the protective immune response induced by E2 in more detail.
Methods
• Insect cells and baculoviruses. Spodopterafrugiperda ceil line Sf21 was used to propagate Autographa californica nuclear polyhedrosis virus (AcNPV) and recombinant baculoviruses (RBVs) (Vaughn et al., I977) . Sf21 cells were routinely grown in either SF900 serum-free medium (Gibco-BRL) plus antibiotics (Funchizone 62"5 txg/ml, peniciIlin 125 mU/ml and streptomycin 125 ng/ml) or TC100 medium (Gibco-BRL) (Grace, 1962) supplemented with I0% fetal calf serum (FCS) and antibiotics. For transfections, Sf2I cells were grown in Grace's supplemented medium (Gibco-BRL) with 10% FCS and antibiotics.
• Construction of baculovirus transfer vectors. Plasmid pPRc34 contains the E2 gene of CSFV strain C (van Rijn et al., 1992) . Plasmids pPRb9 (van Rijn et al., 1992) , pPEh14 and pPEh18 (van Rijn et al., I993) , and pPK01, pPK32 and pPK34 (van Rijn et al., 1994) Deletion of the transmembrane region (TMR) and introduction of a stop codon at position I032 were carried out by amplification (PCR) of the E2 gene of pPRb9 and pPRc34 under standard conditions (94 °C for lmin, 55 °C for lmin, 72 °C for l min) with primers A (5' AGATTGGATCCTAAAGTATTAAGAGGACAGGT 3') and B (5' TAGTCGGATCCTTAGAA.TTCTGCGAAGTAATCTGA 3'). The nucleotide sequences of the amplified E2 genes were checked by sequencing after cloning the BamHI fragments in pGEM-4Z (Promega). Thereafter, the same BamH[ fragments were recloned in the transfer vector pAcMOS, a derivative of pAcAS3 (Vlak et aL, 1990) which contains an ATG start codon upstream of the BamHI site (J. Vlak, University of Wageningen, The Netherlands, personal communication). Transfer vectors with the wild-type E2 genes without TMR (E2 --TMR) of strains Brescia and C under the direction of the baculovirus pl0 gene promoter were designated pPAblI and pPAcI0, respectively. BacuIovirus transfer vectors pPAbI2 to pPAbI6 were constructed by exchange of the NheI-BglII fragment of pPAb11 for NheI-BglII fragments of the mutated E2 genes described above (Fig. 2) . All cloning procedures were carried out according to standard procedures and plasmids were
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• Regeneration and selection of RBVs. RBVs expressing E2 proteins were regenerated and selected as described (Hulst et aL, I993) with some small modifications. Blue virus plaques were picked and tested in an immunoperoxidase monolayer assay (IPMA) for E2 expression with a mixture of horseradish peroxidase-conjugated MAbs directed against E2, essentially as described by Wensvoort et al. (1986) . RBVs expressing (mutant) E2 were plaque purified approximately 2-3 times. Virus stocks were prepared and stored at 4 °C or -70 °C. The RBVs were designated bac.cE2, bac.bE2, bac.bE2(dBC), bac.bE2(dA), bac.bE2(T834), bac.bE2(C792) and bac.bE2(C828).
• Analysis of radiolabelled E2 proteins. Radiolabelling, immunoprecipitation and glycopeptidase F (PNGase F) treatment were performed essentially as described (Hulst et aL, 1993) . Briefly, confluent monolayers of Sf21 cells were infected with purified RBV at an m.o.i, of t0 for 1"5 h at room temperature. After incubation at 29 °C in flesh SF900 medium for 40 h, medium was replaced with Grace's methionine-free medium containing 40,,Ci of [aSS]methionine (Amersham). Medium was harvested after 6 h and clarified by centrifugation for 10 min at 600 g'. E2 proteins were immunoprecipitated with a mixture of E2-specific MAbs. Immunocomplexes bound to protein A-Sepharose were treated with PNGase F and analysed by SDS-10% PAGE (Laemmli, I970) . After electrophoresis, gels were fixed in 10% methanol-7% acetic acid, dried and exposed to Hyperfilm-MP (Amersham).
• Immunoaffinity purification of E2 protein. MAbs b4 and bS, directed against different E2 structural antigenic units of CSFV strain Brescia, were used to purify E2 from the medium of insect cells infected with RBVs. Media were harvested and clarified by centrifugation for i0 min at 600 g. Except for bac.bE2(dBC), all clarified media as well as that from wild-type AcNPV-infected cells were incubated with Sepharose beads coupled with MAb b5. Medium of cells infected with RBV bac.bE2(dBC) was incubated with Sepharose beads coupled with MAb b4. After 16 h at 4 °C, bound E2 was recovered by centrifugation for 3 min at 3000 g and washed 3 times by resuspending the beads in 4 vols of Tris-HC1 (pH 8'0). Then, E2 was eluted in 0"1 M-glycine-HC1 (pH 2'5) by centrifugation as described above. Elution was repeated twice and E2-containing solutions were immediately neutralized with 3"0 M-Tris (pH 10"0). Purity was determined by SDS-PAGE and Coomassie brilliant blue (CBB) staining. The amounts of E2 proteins in the pooled fractions were quantified by comparison with a known amount of E2 (Hulst et al., 1993) .
• Immunization and challenge of pigs. On day 0, five groups (A to E) of four specified-pathogen-free (SPF) 6-to 10-week-old pigs and one group (F) of two SPF pigs were inoculated intramuscularly with a double water-oil emulsion (Herbert, 1965; Barreling & Vreeswijk, 1991) of medium of RBV-infected insect cells containing about 4 gg (mutant) E2 protein. One control group of two SPF pigs (G) was not inoculated. After 28 days, inoculated pigs were boosted with about 15 ~,g immunoaffinity purified (mutant) E2. On day 42, pigs of all groups were intranasally challenged with 100 LD~0 of CSFV strain Brescia 456610 (Terpstra & Wensvoort, 1988) . Serum samples were taken on days 1, 21, 28, 42 and 56. Heparinized (EDTA) blood was sampled on days 40, 42, 45, 47, 49, 5 I, 53 and 56. All pigs were observed daily for signs of disease, and body temperatures were measured. Titres of neutralizing Abs were determined using the neutralizing peroxidase-linked antibody assay (NPLA) as described by Terpstra et al. (1984) . Determination of all Abs specific for E2 (neutralizing and non-neutralizing) was carried out with the complex trapping blocking (CTB) assay (Wensvoort et al., I986) . The CTB assay is routinely used to diagnose animals for Abs directed against E2 of CSFV. Inhibition above 50 % is considered positive. Thrombocytes in the EDTA blood samples were counted and the amounts of infective CSFV were determined by endpoint dilution titration of freeze-thawed leukocyte fractions on SK-6 cells using horseradish peroxidaseconjugated MAbs.
Results

Construction of recombinant baculoviruses containing mutant E2 genes
Mutant E2 genes were selected for expression in insect cells in order to study the immune response induced by E2 in more detail (Fig. 2) . Two selected mutants were E2 genes in which one of the two antigenic units, unit B/C or unit A, was deleted. Two other selected mutants contained mutated cysteine residues involved in the formation of proposed sulphur bridges important for the antigenic structure of unit A ( Fig. 1; van Rijn eta]., 1994). Although the entire amino acid backbone is still present in these mutants, it was expected that the induction of Abs directed against unit A would be strongly reduced. The fifth mutant contained a Thr--* Ile mutation at position 834. Threonine at position 834 was found to be essential for all conserved epitopes of domain A (van Rijn et aL, 1994) .
In order to promote secretion into the medium, baculovirus transfer vectors containing E2 genes without TMR (E2mTMR) were constructed (HuM et al., 1993) . However, in contrast to Hulst eta] ., who used the signal sequence of the gX-gene of pseudorabies virus (PRV), we incorporated the native signal sequence of E2. Sf21 cells were cotransfected with the constructed baculovirus transfer vectors and wild-type AcNPV DNA from extracellular virus particles. Virus plaques expressing fl-galactosidase were isolated and analysed for expression of E2. The signal sequence of E2 appeared to be as functional as the signal sequence of gX-protein of PRV, since all mutant E2 genes were detected by several MAbs (Table 1) . Subsequently, three to five independent RBVs for each E2 insert were plaque purified. Growth of RBVs and titres were similar and independent of the inserted (mutant) E2 genes (data not shown). Stocks of purified RBVs, bac.cE2, bac.bE2, bac.bE2(dBC), bac.bE2(dA), bac.bE2(C792), bac.bE2(C828) and bac.bE2(T834) were prepared with titres of about 108 p.f.u,/ml. These virus stocks were used for further studies.
Reaction of MAbs with mutant E2 proteins
Binding of MAbs to mutant E2 proteins expressed in Sf21 cells was studied by IPMA (Wensvoort ef a] ., 1986). Specificity of the MAbs was checked by infection of monolayers at a low m.o.i. In the case of negative (-) or weak ( 4-) immunostaining, the infection was checked by a second immunostaining with another MAb. As expected, IPMA results of Sf21 cells infected with bac.cE2, bac.bE2, bac.bE2(dBC) and bac.bE2(dA) corresponded with the previous results obtained in transfected COS-1 cells transiently expressing these E2 proteins (van Rijn :73~ 
* Position of the mutation/deletion with respect to the amino acid sequence of CSFV strain Brescia. ~-Antigenic (sub)domains, A(I-3) to C of E2 of CSFV strain Brescia and structural antigenic unit B/C of E2 of strain C were defined as described
* MAbs raised against CSFV strains Brescia (b2 to b12) and C (c2 and c6) are indicated.
et al., 1992, 1993 ; see Table 1 ). MAbs directed against domains B and C of CSFV strain Brescia recognize bE2 and bE2(dA) and not cE2 and bE2(dBC), whereas MAbs directed against conserved epitopes of domain A bind to cE2, bE2 and bE2 (dBC) and not to bE2(dA). Furthermore, non-conserved MAb b12
binds to bE2 and bE2(dBC) and not to cE2 and bE2(dA). Finally, MAbs c2 and c6, specific for strain C, bind to cE2 and not to the other proteins. In contrast, the IPMA results with bac.bE2(C792), bac.bE2(C828) and bac.bE2(T834), containing E2 genes with a point mutation, differed with respect to transient expression in transfected COS-I cells. In this respect it is striking that MAbs which immunostained COS-1 cells expressing a particular mutant E2 protein also detected this mutant E2 protein in Sf21 cells but not vice versa. In infected Sf21 cells, in which the expression of E2 is much higher, the reduced affinity of some MAbs for mutant E2 proteins bE2(T834), bE2(C792) and bE2(C828) appeared to be sufficient for positive immunostaining. Differences, however, were only found with MAbs b2, b3 and bT, whereas negative immunostaining in COS-1 cells with MAbs b4, b9, bl0 and b12 was also negative in infected insect cells.
Processing and secretion of mutant E2 proteins
We expressed E2 proteins without TMR resulting in secretion of (mutant) E2 protein into the medium. Concentrations of secreted mutant E2 proteins were quantified by comparison with standardized amounts of E2 protein (Hulst et a] ., 1993). Independent plaque-purified RBV-infected cells secreted comparable amounts of E2 proteins. The concentration (+ 100 ~lg/ml medium) of secreted E2 protein produced by infection with RBVs containing intact E2 genes originating from strain Brescia or strain C showed a variation between I0 % and 20 % (data not shown). Variation in concentration of different mutant E2 proteins, however, was significantly higher. Deletion E2 proteins were produced in lower concentrations; about 30 ,g/ml for bE2(dBC) and about 4 lig/ml for bE2(dA). The other mutant E2 proteins, bE2(C792), bE2(C828) and bE2(T834), were secreted in concentrations of about 8, 8 and 90 mg/ml, respectively. Since the E2 genes are under the direction of the same transcription and translation signals, no variation in expression was expected. Probably, the synthesis and/or stability of the E2 proteins were affected by the mutations.
Processing of secreted E2, originating from CSFV strain Brescia, was investigated by radio-immunoprecipitation with a mixture of three E2-specific MAbs and treatment with PNGase F (Fig. 3) . The protein was precipitated from the medium as a band of about 49 kDa and as a band of about 42 kDa after digestion with PNGase F (lanes I and 2, respectively). This 42 kDa band probably represents the non-glycosylated backbone of E2--TMR. These observations correspond to M wt dA dBC 834 792 828 M I-+1-+1-+1-+1-+1-+1 i:: ::i:::::: :::::::::::::::::::::::::::::::::::::::::: !::::::i:::::: ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: :. iy{~ ~+~i ĩ :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: previous results of Hulst et al. (1993) . This indicates that use of either the signal sequences of E2 or of PRV gX results in a similar processing of secreted E2. The size of E2 from Sf21 cells infected with bac.bE2(dA) was significantly smaller than bE2 (lanes 3 and 4). The backbone of bE2(dA) is about 34 kDa in size, which, compared to about 42 kDa of bE2, confirmed the deletion of 64 amino acids. The difference in size between glycosylated and non-glycosylated bE2(dA) is about 3 kDa, suggesting one occupied N-linked glycosylation site on bE2(dA). Since the difference in mobility of bE2 after PNGase F treatment is larger ( -4-7 kDa), it is likely that the deletion of bE2(dA) encompasses at least one occupied N-linked glycosylation site. Protein bE2(dBC) is also glycosylated, since the molecular mass of bE2(dBC) is reduced after PNGase F treatment (lanes 5 and 6). The molecular mass of the backbone of bE2(dBC) is about 35 kDa, which is significantly less than that of bE2 (4-42 kDa) and slightly more than the molecular mass of bE2(dA) ( ± 34 kDa). This agrees with the deletion of 53 amino acid residues in bE2(dBC) and a deletion of 64 amino acids in bE2(dA). E2 proteins with a point mutation, bE2(T834), bE2(C792) and bE2(C828), showed no differences with respect to bE2 (lanes 7 to 12), indicating that secretion and glycosylation were not affected by these point mutations.
Vaccination and challenge of pigs
To perform vaccination experiments with highly concentrated E2, we isolated and concentrated mutant E2 proteins by immunoaffinity chromatography. Purifications were monitored by SDS-PAGE of samples from each step and then protein staining with CBB. A representative result of the bE2 protein purification is shown in Fig. 4 iiii; i{ :iiiii;;ii!ii;;iiii;:iiiii; U::iiii ii:;ii: i;;ii::i::ii:;i :iii:i:: i :i::ii iii::g;:;: ::Ng !iNa::ai gN ;: * Results of the CTB assay are expressed as percentage of inhibition. The interpretation of these percentages is as follows: < 30% is negative, between 30% and 50% is 'doubtful' and > 50% inhibition is definitely positive. T Results of the NPLA are expressed as the reciprocal of the serum dilution neutralizing I00 TCIDs0 of CSFV strain Brescia in 50% of the replicate cultures. :1: Clinical signs of disease were; fever, anorexia, leucopenia, thrombocytopenia and paralysis. Presence or absence of these signs are indicated, in that order, by + or -.
liquid was almost free of the dominant protein band of about 69 kDa. In the first elution step, the major part of purified bE2 is present in concentrations up to 500 lag/ml and with a purity of more than 95 %.
Since purified E2 proteins were not available on day 0 of the experiment, pigs were first inoculated with medium of infected insect cells containing about 4 lig (mutant) E2 proteins. A CTB assay was performed in order to investigate Ab responses (Table 2 ). In the CTB assay, an indirect blocking ELISA, the binding of both MAb b3 and Mab b8, directed against unit A and unit B/C, respectively, is crucial for staining and indicates a negative test result. Ab responses raised against one or both antigenic domains will block binding of at least one of these MAbs and indicates a positive test result. On day 2I after the first vaccination, three out of four pigs of group bE2(T834) were tested as positive (> 50% inhibition) in the CTB assay (Table 2 ). In contrast, on day 28 after the first vaccination pigs of the other groups, including wild-type E2, were tested as negative or 'doubtful'. Based on these results, we decided to revaccinate the animals on day 28 with 15 lig purified (mutant) E2 protein. None of the pigs showed fever after immunization with unpurified and purified protein preparations. Two weeks after the revaccination (day 42 of the experiment), significant percentages of inhibition (> 50% inhibition) were found in all vaccinated animals.
We also investigated Ab responses induced by (mutant) E2 proteins by NPLA ( Table 2 ). The NPLA detects the total amount of neutralizing Abs by inhibition of CSFV infection (Terpstra et al., I984) . The increase of the NPLA titre in sera of pigs immunized with bE2(T834) was comparable with that of i i iiiiiiiiiiiiiiiii!!iiiiiiiili intact E2. The induction of neutralizing responses in pigs immunized with the other mutant E2 proteins was delayed. This slower increase of Ab responses is more evident in sera of pigs immunized with deletion E2 proteins than with E2 containing a Cys--* Ser mutation. In conclusion, however, only small differences between neutralizing responses induced by one or both structural antigenic units were detected with the NPLA. Two weeks after revaccination (day 42 of the experiment), NPLA titres were mostly above 3000 in all vaccinated animals.
Pigs were challenged with 100 LDs0 of CSFV strain Brescia 456610 on day 42 after the first vaccination. All animals inoculated with (mutant) E2 proteins appeared to be protected against this challenge. A few animals developed fever for one or two days, on days 4, 5, or 6 post-challenge. One pig, no. 783, showed symptoms of anorexia, but the animal recovered. No virus was detected in leukocyte fractions taken up to 2 weeks post-challenge and no significant deviations were observed in thrombocyte counts. In contrast, the control animals developed fever ( > 40 °C) from day 3, were viraemic and were euthanized when moribund at day 8. In conclusion, the immune response induced by one structural antigenic unit, unit B/C or unit A, is sufficient for protection of pigs against a lethal CSFV challenge.
Discussion
Envelope glycoprotein E2 as well as several mutants of CSFV E2 were successfully expressed in insect cells using the bacuIovirus expression system. As previously described by HuM et aI. (1993) , E2 without TMR is secreted into the medium and therefore the level of expression is probably 10 times higher than that of E2 with TMR (E2 + TMR), which stacks in the cell. We therefore cloned mutant E2 genes without TMR in the baculovirus transfer vector to provide secretion and high level expression. Furthermore, the native signal sequence of E2 was used instead of the signal sequence of PRV gX (HuM et al., 1993) . Both signal sequences appeared functional in transport of E2 through the membrane of the endoplasmic reticulum.
Under similar conditions, the concentrations of several mutant E2 proteins varied between 3 ~tg/ml for bE2(dA) to above 100 I~g/ml for bE2. Efficiency of expression and secretion of heterologous proteins from insect cells is unpredictable and largely dependent on the protein under investigation (King et al., 1992) . Since the position of the E2 gene in the pl0 locus is the same for all constructs, the efficiency of transcription and translation will be similar for all RBVs used in this study. This was confirmed by the small variation in E2 levels found for RBVs containing the same E2 gene, originating from independent cotransfections (data not shown). Therefore, variation in concentrations of different E2 proteins has to be due to the introduced mutations. Possibly, mutations in E2 cause accumulation of protein in the cell, which inhibits synthesis of the protein as has been found for E2 + TMR (Hulst et al., 1993) , or the stability of E2 in, or outside, the cell is affected by the mutation. Presumably, mutations drastically changing the overall structure of E2 will significantly affect synthesis or stability of E2. The structures of bE2(dA) with an internal deletion, and bE2(C792) and bE2(C828) with a blocked disulphide bond had likely changed to such an extent that they showed a strong reduction of mutant E2 expression with respect to bE2 (see Results). On the other hand, mutations in E2 which presumably do not affect the overall structure of the protein, like the point mutation in bE2(T834), do not affect the level of E2 expression. Finally bE2(dBC) was expressed to a reduced concentration of about 30 p.g/ml with respect to bE2 (100 ~g/ml). Apparently, an Nterminally located deletion in E2 affected the level of expression less than an internal deletion or the blocking of a disulphide bond.
Most IPMA results obtained with insect ceIIs matched the results in COS-I cells; however, some remarkable differences were observed between these two expression systems (Table  1) . Firstly, all differences are obtained with point mutations. This indicates that point mutations reduce, but do not per se abolish the affinity of MAbs for mutated epitopes. Secondly, with some MAbs negative results in COS-1 cells were obtained, whereas these MAbs immunostained insect cells expressing the corresponding mutant E2 protein, but not vice versa. Obviously, despite the reduced affinity of MAbs for their mutated epitopes, higher concentrations of mutant E2 protein can result in detectable immunostaining. Thirdly, differences were only found with neutralizing MAbs. Apparently, the reduced affinity of neutralizing MAbs for mutated epitopes can still be sufficient for immunostaining in insect cells, whereas the affinity of non-neutralizing MAbs for their mutated epitopes is too low for detection. Possibly, binding of neutralizing MAbs is stronger than binding of non-neutralizing MAbs.
MAbs directed against epitopes of antigenic domain A can bind to mutated antigenic unit A of E2 (Table 1) . Consequently, E2 proteins with a mutated structural antigenic unit A will induce Abs in pigs recognizing wild-type E2. Of course, E2 with a deleted structural antigenic unit A, bE2(dA), will not induce Abs against antigenic domain A. Likewise, bE2(dBC) will not induce Abs directed against antigenic domains B and C. Except for bE2(T834), a slower increase of NPLA titres induced by mutant E2 proteins compared to wild-type E2 was observed (Table 2 ). This might be caused by the absence of Abs directed against one structural antigenic unit and/or the absence of synergism of neutralization (Wensvoort, 1989a) . Apparently, the Thr ~ Ile mutation has a less drastic effect on induction of neutralizing Abs than deletions or Cys--* Ser mutations in E2. Probably bE2(T834) is even more immunogenic than intact E2, since a single vaccination with this mutant protein resulted in percentages of inhibition above 50 % in the CTB assay. We cannot explain this observation, but based on :74~ these results, this mutant E2 protein might be an even better candidate for subunit vaccine development than wild-type CSFV E2.
The CTB assay seems to be more sensitive than the NPLA. 'Doubtful' (between 30% and 50%) and even positive (between 52 % and 64 %) percentages of inhibition were found negative in the NPLA (< 25); however, there were some exceptions (animals 778 and 792). Above 70 % inhibition in the CTB assay was completely correlated to an observed neutralizing Ab response (> 25) with the NPLA. Animals showing a positive result with the CTB and a detectable NPLA titre (> 25) were all protected, and only a few animals had fever for a few days. This is in agreement with the findings of Terpstra & Wensvoort (1988) , who observed protection with NPLA titres above 25. The vaccinated animal (783) with the lowest percentage of inhibition (64%) and no detectable neutralizing Ab response showed symptoms of anorexia, but recovered and showed no viraemia. In general, the percentage inhibition in the CTB and NPLA titre are inversely correlated to clinical signs of disease.
We narrowed the spectrum of Abs essential for protection by demonstrating that immunization with deletion E2 proteins bE2(dA) and bE2(dBC) protects pigs against a lethal homologous CSFV challenge. These results support the proposed model of E2 antigenic structure in which the antigenic domains are located on two independently formed structural antigenic units ( Fig. 1 ; van Rijn et aI., 1994) . The deletion mutants of E2 were the smallest truncated forms of E2 tested in this study. We have not yet succeeded in determining the minimal response sufficient for protection. As epitopes on both structural antigenic units are conformational, it can be imagined that the smallest part of E2 sufficient for protection has to encompass the cysteine residues essential for this conformation. Therefore, it is predictable that a peptide from Cys 69a to Cys vaT, which encompasses non-conserved antigenic domains B and C is protective against the homologous CSFV strain. Even so, a peptide from Cys 79z to Cys 8~6 containing a highly conserved antigenic domain A will probably protect animals against all CSFV strains.
In conclusion, here we have shown that the immune response induced by deletion E2 proteins containing one structural antigenic unit is protective against CSFV. This finding opens the way to the development of a marker vaccine (dead or live-attenuated) for classical swine fever, in which both protection and serological differentiation are based on the immunogenic envelope glycoprotein E2. The absence of Abs directed against one structural antigenic unit of E2 can be used to develop a diagnostic test to discriminate between infected and vaccinated animals. Studies to develop such an accompanying diagnostic test and to investigate protective properties of deletion E2 proteins are in progress.
